Can you get medical cannabis for insomnia or sleep problems in the UK?
Sleep is the symptom people most often want fixed, and the one least often prescribed for on its own. UK specialists generally consider sleep problems where they are tied to an underlying condition already being treated — chronic pain, PTSD, a neurological condition — rather than as a stand-alone reason to prescribe.
The short answer
- Stand-alone insomnia is rarely a route in. Sleep is usually assessed alongside another condition.
- CBT-I is the recommended first treatment for insomnia in the UK, ahead of any medicine.
- Sleep apnoea must be excluded — sedating medicines can make it worse, sometimes dangerously.
- One randomised crossover trial of a cannabinoid extract in chronic insomnia showed improvement.
- Tolerance and rebound insomnia are recognised problems with regular use.
Are sleep problems treated with medical cannabis in the UK?
Usually as part of treating something else. Where a specialist is already assessing you for chronic pain, PTSD, MS or another long-term condition, sleep is one of the outcomes they will track and try to improve. Insomnia on its own, with no underlying condition, is not a typical route to a private prescription in the UK.
The reason is that insomnia has a well-evidenced first-line treatment that is not a medicine. Cognitive behavioural therapy for insomnia (CBT-I) is recommended ahead of drug treatment in UK practice, is available through the NHS in some areas and through digital programmes, and produces durable improvement in a way that sedatives generally do not. NICE guidance on insomnia points the same way, with hypnotics reserved for short-term use.
There is also a diagnostic question that has to come first. Poor sleep can be a symptom of obstructive sleep apnoea, restless legs syndrome, depression, an overactive thyroid or a circadian rhythm disorder — each of which needs a different treatment, and some of which are made worse by sedation.
What the evidence actually shows
There is one properly conducted randomised trial in chronic insomnia, and it is small but positive. Nothing about it establishes cannabis-based medicines as an insomnia treatment, and the trial's own authors called for larger studies.
The ZTL-101 trial, published in Sleep, was a randomised, double-blind, placebo-controlled crossover study of a two-week nightly sublingual cannabinoid extract in 23 people with chronic insomnia. Compared with placebo, it reduced Insomnia Severity Index scores by about five points, shortened self-reported time to fall asleep, increased total sleep time and improved sleep quality and feeling rested on waking. Forty mild adverse events were reported, most resolving overnight; there were no serious adverse events.
Twenty-three people over two weeks tells you little about months of use, and nothing about tolerance — the tendency for sedative effects to diminish with regular use, which is well recognised with cannabis and is the usual reason doses creep upward.
The study behind that paragraph
Walsh JH, Maddison KJ, Rankin T, et al. Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo. Sleep. 2021;44(11):zsab149. A two-week randomised placebo-controlled crossover trial in 23 people with chronic insomnia, reporting improved insomnia severity, sleep latency and total sleep time.
What a specialist will want to see
There is no UK list of qualifying conditions, so nothing here entitles you to a prescription. A specialist works through your history and decides whether a monitored trial is justified for you. For sleep problems they will typically look at:
- Whether an underlying condition is driving the sleep problem, and whether it is being treated
- Whether you have been screened for obstructive sleep apnoea, particularly if you snore or wake unrefreshed
- Whether you have tried CBT-I, and whether you were able to complete it
- Your sleep pattern, shift work, caffeine, alcohol and screen habits — assessed properly, not dismissed
- Which sleep medicines you have used, including over-the-counter ones, and for how long
- Depression and anxiety, which frequently present as insomnia and need treating in their own right
The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?
Risks and reasons a specialist may say no
Sleep apnoea is the risk that matters most and is most often missed. Sedating medicines can worsen breathing interruptions during sleep, so a specialist should screen for it before prescribing anything sedating — not after.
Tolerance develops with regular use, meaning the same dose does less over time, and stopping after regular use commonly causes rebound insomnia and vivid dreams that can feel worse than the original problem. THC also suppresses REM sleep, and the long-term consequences of that are not well characterised. Next-day drowsiness affects driving. As elsewhere, a personal or family history of psychosis, unstable mental illness, pregnancy and breastfeeding count against treatment.
How medical cannabis is thought to help
Any account of how cannabis-based medicines affect sleep has to hold two things together: the short-term sedative effect is real and easy to feel, while the longer-term picture is more complicated and less favourable than it first appears.
The body has its own endocannabinoid system — a network of receptors and signalling molecules involved in regulating the sleep-wake cycle, mood, the stress response and appetite. THC and CBD interact with it in different ways: THC acts directly on cannabinoid receptors and is responsible for the intoxicating effects, and can shorten the time it takes to fall asleep while also suppressing REM sleep; CBD works more indirectly and is not intoxicating. If you want the underlying biology rather than the condition-specific picture, the guides on the endocannabinoid system and THC and CBD set it out in plain terms.
Feeling drowsy is not the same as sleeping well, and the sedative effect tends to fade with regular use — which is why a specialist treats an early improvement in sleep as a starting point to monitor, not a result to rely on.
What treatment involves in practice
Where a specialist does decide a monitored trial is justified — usually as part of treating an underlying condition rather than sleep alone — treatment follows the cautious pattern used across this field: start low, increase slowly, and review often.
Unlicensed cannabis-based products are prescribed on a named-patient basis, which places responsibility for the decision and for informed consent with the specialist rather than with a manufacturer's licence. Treatment usually begins at a low dose and is titrated upwards gradually, so that any benefit and any side effects can be judged against small, deliberate changes. Most prescriptions take the form of an oil or capsule taken by mouth, or dried flower for vaporising; the two behave differently in how quickly they act and how long they last, which is covered in how cannabis-based medicines are taken and how long they take to work.
Follow-up reviews matter especially with sleep, where tolerance can push doses upward and where next-day drowsiness affects daytime function and driving. They are where the specialist checks whether sleep is genuinely better, whether the dose is creeping up, and whether treatment should continue or stop. How a dose is set and changed is explained in how a dose is decided and adjusted, the questions of tolerance and stopping in tolerance, dependence and stopping treatment, and the practical side of driving in the guide on driving with a medical cannabis prescription.
If you want to take this further
The useful next step is a proper assessment, not a better list. Gather your diagnosis, the treatments you have already tried and what happened with each, and your current medicines — that is what a specialist needs in order to give you a straight answer.
The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If sleep problems is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.
Frequently asked questions
Can I get medical cannabis for insomnia in the UK?
Rarely on its own. Sleep problems are usually considered where they are linked to an underlying condition a specialist is already treating, such as chronic pain or PTSD. Stand-alone insomnia is normally directed to cognitive behavioural therapy for insomnia first, which is the recommended UK treatment.
Is there trial evidence for sleep?
One randomised, placebo-controlled crossover trial of a nightly cannabinoid extract in 23 people with chronic insomnia found improvements in insomnia severity, time to fall asleep and total sleep time over two weeks. It is a small, short study and the authors called for larger trials.
Why does sleep apnoea matter?
Because sedating medicines can worsen the breathing interruptions that define obstructive sleep apnoea. If you snore heavily, wake unrefreshed or have been told you stop breathing in your sleep, you should be screened for it before any sedating treatment is considered.
Will I become tolerant to it?
Tolerance to the sedative effects is well recognised with regular cannabis use, which is why doses tend to creep upward. Stopping after regular use commonly causes rebound insomnia and vivid dreams. A specialist should discuss this before starting, not after.
How is medical cannabis usually taken?
Most prescriptions are either an oil or capsule taken by mouth, or dried flower for vaporising. Oils and capsules tend to act more slowly and last longer, while vaporised flower acts faster and wears off sooner. Your specialist decides the format and starting dose with you, and treatment usually begins at a low dose and is increased slowly.
How long before I know if it is working?
There is no fixed answer, and judging it is one of the things a follow-up review is for. Because treatment starts low and is titrated slowly, a fair trial is measured in weeks rather than days. If it is not helping, or if side effects outweigh any benefit, a specialist should stop it rather than persist.
Do I have to tell my GP?
It is strongly advisable. Your GP holds your full medical record and prescribes your other medicines, so keeping them informed helps avoid interactions and keeps your care joined up. A specialist will normally ask for access to your records as part of the assessment for this reason.
Sources and further reading
Every factual statement on this page is drawn from the following public sources. Links open in a new tab and are not affiliated with Flora House.
- Walsh JH, et al. Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo. Sleep (2021)
- NICE Clinical Knowledge Summary: Insomnia
- NHS: Insomnia
- NICE guideline NG144: Cannabis-based medicinal products
- NHS: Medical cannabis (and cannabis oils)
- House of Commons Library briefing CBP-8355: Medical use of cannabis
- MHRA: The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use